Search results

Selected filters:

North America
Technology Licensing

Article type

Topic

Sector

Jurisdictions

333 results found for your search

Sort options
04 October 2019

The new China dynamic, pool progress and more from our Patent Licensing event

The big takeaways from a day of deal-making discussions in the heart of Silicon Valley

04 October 2019

How AstraZeneca found success in out-licensing, in-licensing and a revamped R&D strategy

A steep patent cliff in 2012 forced the Anglo-Swedish company to rethink its entire operation – and the results have shown the right calls were made

30 September 2019

ITRI spin-out is plaintiff in latest genomics patent campaign

Taiwan’s Personal Genomics is going after an acquisition target of Illumina, the top player in the sequencing space

28 September 2019

The US is gifting 5G patent leadership to others

Policy confusion and problematic court decisions mean that the shape of the IP landscape in this pivotal technology is being determined elsewhere

27 September 2019

Huawei’s FRAND strategy: move cases to China

The company wants to shift disputes to its home jurisdiction and persuade courts there to set a low, China-specific rate

27 September 2019

Banks bet on purchases, not patents, to take on tech giants in fintech

Mastercard and the Bank of America may be investing heavily in their portfolios, but most traditional players favour company acquisitions and collaborations to stay in the game

23 September 2019

Nanjing judge sets Chinese SEP rate in dispute between Conversant and Huawei

Chinese court has had its say on royalties - and it looks like the telecoms giant has got exactly what it was looking for

23 September 2019

With no sign of trade war compromise, DOJ official attacks Chinese system that “encourages and rewards IP theft”

Comments by Deputy Assistant Attorney General in interview also suggests that the US will continue to take a more proactive approach to policing security risks in telecoms networks  

21 September 2019

Huawei’s 5G spinoff bluff shows why export ban will hurt US tech firms

CEO Ren Zhengfei doesn’t think another company can build a business around Huawei’s 5G technology stack. Not only will the company's predicament not help US tech firms, it is actively hurting them

20 September 2019

WiLAN patent purchase shows semiconductor space remains a happy hunting ground for NPEs

Deal with Mediatek involves package of global families and comes months after Canadian licensing company’s deal with Nvidia

19 September 2019

After Congressional hearing, still no clarity over US government divide in FTC v Qualcomm

SEP owners left in the dark following Senate committee session in which antitrust chiefs Delrahim and Simons played down significance of split in agencies' views of key case

18 September 2019

Plaintiff state entities cannot claim sovereign immunity, says CAFC in precedential decision

Ruling is the latest setback for patentees in this controversial area and comes as the University of Minnesota seeks a Supreme Court review of its IPR immunity-related dispute with LSI

16 September 2019

Genentech dispute highlights growing importance of trade secrets for life sciences companies

Legal and commercial developments suggest that disputes over increasingly valuable biopharma know-how, proprietary information and data will increase in years to come.

16 September 2019

TiVo CEO: expect company split in first half of next year

Licensing business will take on company debt and needs to be “willing to litigate and litigate for years”

12 September 2019

Huawei CEO: our 5G IP can be had for an upfront fee

Ren Zhengfei welcomes telecom equipment competition with a grandiose offer, but some key details are still open to question